Icon Advisers’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-162,431
Closed -$10.4M 334
2018
Q4
$10.4M Buy
162,431
+250
+0.2% +$18.5K 1.09% 25
2018
Q3
$14.5M Sell
162,181
-15,937
-9% -$1.41M 1.23% 18
2018
Q2
$14.1M Buy
178,118
+40,699
+30% +$3.38M 1.07% 24
2018
Q1
$12.3M Sell
137,419
-30,695
-18% -$2.95M 0.93% 30
2017
Q4
$17.5M Buy
168,114
+35,854
+27% +$4.05M 1.21% 17
2017
Q3
$19.3M Buy
132,260
+140
+0.1% +$19.1K 1.35% 7
2017
Q2
$17.2M Sell
132,120
-12,300
-9% -$1.51M 1.19% 6
2017
Q1
$18M Buy
144,420
+9,700
+7% +$1.16M 1.23% 5
2016
Q4
$15.6M Sell
134,720
-1,400
-1% -$156K 1.06% 7
2016
Q3
$14.2M Buy
136,120
+3,500
+3% +$379K 0.94% 9
2016
Q2
$13.1M Hold
132,620
0.89% 19
2016
Q1
$13.3M Sell
132,620
-9,300
-7% -$958K 0.95% 17
2015
Q4
$17M Sell
141,920
-4,900
-3% -$567K 1.16% 10
2015
Q3
$15.9M Sell
146,820
-22,960
-14% -$2.85M 1.1% 17
2015
Q2
$19.6M Sell
169,780
-1,320
-0.8% -$151K 1.23% 14
2015
Q1
$19.7M Buy
171,100
+33,660
+24% +$4.02M 1.16% 19
2014
Q4
$15.4M Buy
137,440
+2,920
+2% +$308K 0.91% 31
2014
Q3
$12.8M Buy
134,520
+3,900
+3% +$352K 0.74% 44
2014
Q2
$11.2M Sell
130,620
-180
-0.1% -$13.7K 0.7% 36
2014
Q1
$9.13M Buy
130,800
+46,580
+55% +$3.69M 0.65% 38
2013
Q4
$7.12M Buy
84,220
+79,800
+1,805% +$6.31M 0.52% 52
2013
Q3
$341K Sell
4,420
-5,360
-55% -$376K 0.03% 272
2013
Q2
$572K Buy
+9,780
New +$589K 0.04% 270

Other funds holding CELG

Icon Advisers's CELG Position: Q1 2019 in Review

Icon Advisers sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 162,431 shares — an estimated $10.4M sold.

Icon Advisers first reported a position in CELG in Q2 2013 and held it in 23 quarters. The position peaked at $19.7M in Q1 2015. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

  • Icon Advisers reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
  • Icon Advisers sold 162,431 Celgene Corp shares in Q1 2019, an estimated $10.4M.
  • Icon Advisers first reported a position in Celgene Corp in Q2 2013 and held it in 23 quarters.
  • Icon Advisers's Celgene Corp position peaked at $19.7M in Q1 2015.
  • 1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on Icon Advisers's 13F filing for Q1 2019, filed 1 May 2019.